Sensus Healthcare (SRTS) Cash & Equivalents (2015 - 2026)

Sensus Healthcare's Cash & Equivalents history runs 12 years deep, the most recent figure standing at $18.3 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 3.91% year-over-year to $18.3 million; the TTM figure through Mar 2026 stood at $18.3 million (down 3.91% YoY), while the FY2025 annual figure was $22.1 million, changed 0.12% from the prior year.
• Cash & Equivalents was $18.3 million for Q1 2026 at Sensus Healthcare, down from $22.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $37.6 million in Q3 2022 to a low of $14.7 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $23.4 million across 5 years, with a median of $22.1 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 140.48% in 2022, then tumbled 45.48% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $25.5 million in 2022, then declined by 9.29% to $23.1 million in 2023, then decreased by 4.72% to $22.1 million in 2024, then rose by 0.12% to $22.1 million in 2025, then fell by 17.01% to $18.3 million in 2026.
• The last three Cash & Equivalents figures came in at $18.3 million (Q1 2026), $22.1 million (Q4 2025), and $24.5 million (Q3 2025), per Business Quant data.